9 Killed in California’s Worst Wildfire in a Century; Kim Kardashian, Other H'wood Stars Forced to Vacate Homes

Agencies
November 10, 2018

Paradise, Nov 10: Wildfires burned out of control on Friday across California, killing at least nine people in a mountain town and forcing residents to flee the upscale beach community of Malibu in the face of a monster fire storm.

All nine victims were found in and around the Northern California town of Paradise, where more than 6,700 homes and businesses were burned down by the Camp Fire, making it one of the most destructive in state history, according to California Department of Forestry and Fire protection data.

"This event was the worst-case scenario. It was the event we have feared for a long time," Butte County Sheriff Kory Honea said at a Friday evening press conference. "Regrettably, not everybody made it out."

The remains of five of the victims were discovered in or near burned out cars, three outside residences and one inside a home, Honea said.

Another 35 people had been reported missing and three firefighters had been injured.

The flames descended on Paradise so quickly that many people were forced to abandon their cars and run for their lives down the sole road through the mountain town.

A school bus was among several abandoned vehicles left blackened by flames on one road.

The Camp Fire, which broke out on Thursday at the edge of the Plumas National Forest northeast of Sacramento, has since blackened more than 90,000 acres and was only 5 percent contained as of nightfall on Friday.

A total of 6,453 homes had been destroyed in Paradise and elsewhere, Honea said, along with 260 commercial buildings. The Tubbs Fire, which destroyed 5,636 structures in Napa and Sonoma counties in October 2017, is listed by Cal Fire as the most destructive in state history.

FIRE BURNS TOWARD MALIBU

In Malibu, some 500 miles (800 km) to the south, flames driven by hot Santa Ana winds gusting up to 50 miles per hour (80 kph) raced down hillsides and through canyons toward multi-million dollar homes.

Thousands of residents packed the Pacific Coast Highway to head south or took refuge on beaches, along with their horses and other pets.

Among those force to flee the Woolsey Fire, which had charred some 35,000 acres (14,164 hectares) as of Friday afternoon, were celebrities, including Lady Gaga and Kim Kardashian, who said on Twitter flames had damaged the home she shares in nearby Calabasas with Kanye West.

"Fire is now burning out of control and heading into populated areas of Malibu," the city said in a statement online. "All residents must evacuate immediately."

Malibu and Calabasas, west of Los Angeles, are home to hundreds of celebrities and entertainment executives attracted by ocean views, rolling hills and large, secluded estates.

The blaze, which spewed massive plumes of thick black smoke, also threatened parts of the nearby town of Thousand Oaks, where a gunman killed 12 people earlier this week in a shooting rampage at a college bar, stunning the bucolic Southern California community with a reputation for safety.

The Woolsey Fire broke out on Thursday and quickly jumped the 101 Freeway in several places. On Friday, it climbed over the Santa Monica Mountains toward Malibu.

Authorities were forced to shut down the 101, a major north-south artery, as well as the Pacific Coast Highway. Los Angeles County Fire Chief Daryl Osby said a "significant number" of homes had been destroyed by the flames but that an accurate count could not yet be made.

Elsewhere, the Hill Fire in Ventura County's Santa Rosa Valley had charred about 6,000 acres (2,428 hectares) as of Friday evening, according to Cal Fire.

In Los Angeles, another, smaller fire in Griffith Park forced the Los Angeles Zoo to evacuate a number of show birds and some small primates on Friday as flames came within less than 2 miles (3 km) of the facility, zoo officials said in a statement.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 22,2020

Karachi, Jun 22: India-born renowned Pakistani Shia scholar and author Talib Jauhari passed away here after a prolonged illness. He was 80.

Jauhari, who was born on August 27, 1939 in Patna, is survived by his three sons, Dawn News reported on Monday.

He migrated to Pakistan along with his father in 1949, two years after the Partition.

After obtaining early education from his father, he went to Iraq where he studied religion for 10 years under the renowned Shia scholars of that time.

Jauhari, who was on a ventilator in the intensive care unit of a private hospital for the past 15 days, breathed his last on Sunday night.

His son Riaz Jauhari confirmed his death and said that the body has been shifted to Ancholi Imambargah for the funeral prayers, The Express Tribune newspaper quoted his son as saying.

Jauhari was respected among his sect as he was a class fellow of the widely revered scholar Ayatollah Sayyid Ali al-Husayni al-Sistani.

He was also a poet, historian and philosopher and authored many books.

Pakistan Prime Minister Imran Khan has condoled Jauhari's death.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.